Additional file 6: Figure S5. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells
2017-05-12T05:00:00Z (GMT) by
Dose–response curves for COV362 cells and three primary HGSOC patient samples (EOC146, EOC183A, EOC183I) to GLN (open circle) or MO-101 (closed diamond). Intersections with the dashed line approximates the CC50 value. Drug doses where there is a significant difference in cell viability between culture conditions or treatments are indicated by an asterisk (*), p < 0.05.